Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.292,40
-0,70%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. AMEX AgeX Therapeutics Inc (AGE) AgeX Therapeutics Inc (AGE) Notizie

AgeX Therapeutics Inc

AGE
11,10
0,00 (0,00%)
26 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/3/202422:27GLOBEAgeX Therapeutics Reports Fourth Quarter and Annual 2023..
07/3/202422:49EDGAR2Form 425 - Prospectuses and communications, business..
07/3/202422:47EDGAR2Form 8-K - Current report
07/3/202413:47EDGAR2Form SC 13D/A - General statement of acquisition of..
14/2/202422:01EDGAR2Form SC 13D/A - General statement of acquisition of..
14/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06/2/202422:05EDGAR2Form 8-K - Current report
05/2/202413:19EDGAR2Form SC 13D/A - General statement of acquisition of..
19/1/202422:05EDGAR2Form 8-K - Current report
17/1/202422:19EDGAR2Form SC 13D/A - General statement of acquisition of..
16/1/202415:11EDGAR2Form S-4/A - Registration of securities, business..
11/1/202422:05EDGAR2Form 8-K - Current report
09/1/202422:16EDGAR2Form SC 13D/A - General statement of acquisition of..
05/1/202422:05EDGAR2Form 8-K - Current report
28/12/202322:02EDGAR2Form 8-K - Current report
18/12/202322:25EDGAR2Form 8-K - Current report
13/12/202323:11EDGAR2Form SC 13D/A - General statement of acquisition of..
08/12/202322:05EDGAR2Form 8-K - Current report
01/12/202322:05EDGAR2Form 8-K - Current report
17/11/202322:05EDGAR2Form 8-K - Current report
16/11/202322:01EDGAR2Form SC 13D/A - General statement of acquisition of..
15/11/202315:38EDGAR2Form DEF 14A - Other definitive proxy statements
14/11/202322:25EDGAR2Form 8-K - Current report
14/11/202322:05BWAgeX Therapeutics Reports Third Quarter 2023 Financial..
07/11/202322:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/11/202322:05EDGAR2Form DEF 14A - Other definitive proxy statements
06/11/202322:05EDGAR2Form 8-K - Current report
01/11/202321:28EDGAR2Form SC 13D/A - General statement of acquisition of..
06/10/202322:05EDGAR2Form 8-K - Current report
22/9/202322:05EDGAR2Form PRE 14A - Other preliminary proxy statements
15/9/202322:05EDGAR2Form 8-K - Current report
08/9/202322:05EDGAR2Form 8-K - Current report
30/8/202322:05EDGAR2Form 425 - Prospectuses and communications, business..
30/8/202313:20EDGAR2Form 8-K - Current report
30/8/202313:00BWSerina Therapeutics and AgeX Therapeutics Enter into Merger..
25/8/202322:05EDGAR2Form 8-K - Current report
24/8/202322:48EDGAR2Form SC 13D/A - General statement of acquisition of..
14/8/202322:25EDGAR2Form 8-K - Current report
14/8/202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:05BWAgeX Therapeutics Reports Second Quarter 2023 Financial..
04/8/202322:05EDGAR2Form 8-K - Current report
25/7/202300:28BWAgeX Therapeutics Closes $36,000,000 Debt Exchange for..
21/7/202323:32BWAgeX Therapeutics Announces $36,000,000 Debt Exchange for..
21/7/202323:29EDGAR2Form 8-K - Current report
07/7/202322:05EDGAR2Form 8-K - Current report
23/5/202322:05BWAgeX Therapeutics Announces Appeal of NYSE American..
12/5/202322:05BWAgeX Therapeutics Reports First Quarter 2023 Financial..
Apertura: Min: Max:
Chiusura: 11,10

La tua Cronologia

AMEX
AGE
AgeX Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network